Literature DB >> 25200584

The association between congenital anomalies and autism spectrum disorders in a Finnish national birth cohort.

Laura Timonen-Soivio1, Raija Vanhala, Heli Malm, Susanna Leivonen, Elina Jokiranta, Susanna Hinkka-Yli-Salomäki, Mika Gissler, Alan S Brown, Andre Sourander.   

Abstract

AIM: The first aim of this study was to evaluate the association between different subgroups of autism spectrum disorders (ASDs) (childhood autism, Asperger syndrome, and pervasive developmental disorder/pervasive developmental disorder - not otherwise specified [PDD/PDD-NOS]) and congenital anomalies. Second, we assessed the association among intellectually disabled children with ASDs in the subgroups of childhood autism and PDD/PDD-NOS.
METHOD: Nationwide population-based register data for children with a diagnosis of ASD (n=4449; 3548 males, 901 females) were collected during years 1987-2000 from the Finnish Hospital Discharge Register. Data on congenital anomalies were derived from the National Register of Congenital Malformations. Conditional logistic regression models were used as a statistical method. The association between ASD subgroups and congenital anomalies was stratified by the presence or absence of intellectual disability.
RESULTS: Congenital anomalies occurred more frequently in all subgroups of ASD than in comparison participants (adjusted odds ratio [OR] for major congenital anomalies 1.8, 95% confidence interval [CI] 1.5-2.2, p<0.001). The association between congenital anomalies and childhood autism (OR 2.4, 95% CI 1.6-3.6, p<0.001) and between congenital anomalies and PDD/PDD-NOS (OR 3.7, 95% CI 2.4-5.7, p<0.001) among children with an intellectual disability was strong but remained significant also without intellectual disability (childhood autism: OR 1.7, 95% CI 1.3-2.3, p<0.001; PDD/PDD-NOS: OR 2.3, 95% CI 1.9-2.8, p<0.001).
INTERPRETATION: The results suggest a significant association between ASDs and congenital anomalies regardless of the ASD subgroup. The association between childhood autism and PDD/PDD-NOS and congenital anomalies is stronger among children with intellectual disability is stronger than among those without intellectual disability. These results may have relevance in examining early risk factors in autism during fetal neurodevelopment.
© 2014 Mac Keith Press.

Entities:  

Mesh:

Year:  2014        PMID: 25200584      PMCID: PMC4267988          DOI: 10.1111/dmcn.12581

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  23 in total

1.  Medical disorders among inpatients with autism in Denmark according to ICD-8: a nationwide register-based study.

Authors:  Marlene B Lauritsen; Ole Mors; Preben B Mortensen; Henrik Ewald
Journal:  J Autism Dev Disord       Date:  2002-04

2.  Trends, perinatal characteristics, and medical conditions in pervasive developmental disorders.

Authors:  Pascale Guillem; Christine Cans; Vincent Guinchat; Marc Ratel; Pierre-Simon Jouk
Journal:  Dev Med Child Neurol       Date:  2006-11       Impact factor: 5.449

3.  A clinicopathological study of autism.

Authors:  A Bailey; P Luthert; A Dean; B Harding; I Janota; M Montgomery; M Rutter; P Lantos
Journal:  Brain       Date:  1998-05       Impact factor: 13.501

Review 4.  The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.

Authors:  J L Waddington; A Lane; C Larkin; E O'Callaghan
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

5.  Essential versus complex autism: definition of fundamental prognostic subtypes.

Authors:  J H Miles; T N Takahashi; S Bagby; P K Sahota; D F Vaslow; C H Wang; R E Hillman; J E Farmer
Journal:  Am J Med Genet A       Date:  2005-06-01       Impact factor: 2.802

6.  Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A): overview and design.

Authors:  Katja M Lampi; P Nina Banerjee; Mika Gissler; Susanna Hinkka-Yli-Salomäki; Jukka Huttunen; Ulla Kulmala; Jarna Lindroos; Solja Niemelä; Maria Rihko; Terja Ristkari; Kristiina Saanakorpi; Tanja Sarlin; Lauri Sillanmäki; Ian W McKeague; Heljä-Marja Surcel; Hans Helenius; Alan S Brown; Andre Sourander
Journal:  J Autism Dev Disord       Date:  2011-08

7.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

8.  Birth defects in children with autism spectrum disorders: a population-based, nested case-control study.

Authors:  Somer Dawson; Emma J Glasson; Glenys Dixon; Carol Bower
Journal:  Am J Epidemiol       Date:  2009-04-16       Impact factor: 4.897

9.  The co-occurrence of autism and birth defects: prevalence and risk in a population-based cohort.

Authors:  Diana E Schendel; Andrew Autry; Roberta Wines; Cynthia Moore
Journal:  Dev Med Child Neurol       Date:  2009-03-30       Impact factor: 5.449

10.  Environmental factors in autism.

Authors:  Andreas M Grabrucker
Journal:  Front Psychiatry       Date:  2013-01-18       Impact factor: 4.157

View more
  10 in total

1.  Brief Report: Syndromes in Autistic Children in a Finnish Birth Cohort.

Authors:  Laura Timonen-Soivio; Raija Vanhala; Heli Malm; Susanna Hinkka-Yli-Salomäki; Mika Gissler; Alan Brown; Andre Sourander
Journal:  J Autism Dev Disord       Date:  2016-08

2.  Child psychiatric epidemiology: stars and hypes.

Authors:  Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-06       Impact factor: 4.785

3.  The association between autism spectrum disorders and congenital anomalies by organ systems in a Finnish national birth cohort.

Authors:  Laura Timonen-Soivio; Andre Sourander; Heli Malm; Susanna Hinkka-Yli-Salomäki; Mika Gissler; Alan Brown; Raija Vanhala
Journal:  J Autism Dev Disord       Date:  2015-10

4.  Mercury-associated diagnoses among children diagnosed with pervasive development disorders.

Authors:  David A Geier; Janet K Kern; Lisa K Sykes; Mark R Geier
Journal:  Metab Brain Dis       Date:  2018-03-06       Impact factor: 3.584

5.  Identification of Essential, Equivocal and Complex Autism by the Autism Dysmorphology Measure: An Observational Study.

Authors:  Sharmila B Mukherjee; Seema Kapoor; Suvasini Sharma
Journal:  J Autism Dev Disord       Date:  2021-05

6.  Rate and Risk Factors Associated with Autism Spectrum Disorder in Congenital Diaphragmatic Hernia.

Authors:  Enrico Danzer; Casey Hoffman; Jo Ann D'Agostino; Judith S Miller; Lindsay N Waqar; Marsha Gerdes; Judy C Bernbaum; Hannah Rosenthal; Natalie E Rintoul; Lisa M Herkert; William H Peranteau; Alan W Flake; N Scott Adzick; Holly L Hedrick
Journal:  J Autism Dev Disord       Date:  2018-06

7.  Assessment of medical morbidities in a rhesus monkey model of naturally occurring low sociality.

Authors:  Adam K Myers; Catherine F Talbot; Laura A Del Rosso; Alyssa C Maness; Sierra M V Simmons; Joseph P Garner; John P Capitanio; Karen J Parker
Journal:  Autism Res       Date:  2021-04-12       Impact factor: 5.216

Review 8.  Environmental factors influencing the risk of autism.

Authors:  Padideh Karimi; Elahe Kamali; Seyyed Mohammad Mousavi; Mojgan Karahmadi
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

9.  Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibility.

Authors:  Yanping Wang; Dione R Gray; Alan K Robbins; Erin L Crowgey; Stephen J Chanock; Mark H Greene; Katherine A McGlynn; Katherine Nathanson; Clare Turnbull; Zhaoming Wang; Marcella Devoto; Julia Spencer Barthold
Journal:  Hum Reprod       Date:  2018-05-01       Impact factor: 6.918

10.  Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study.

Authors:  Manhai Long; Mandana Ghisari; Lisbeth Kjeldsen; Maria Wielsøe; Bent Nørgaard-Pedersen; Erik Lykke Mortensen; Morsi W Abdallah; Eva C Bonefeld-Jørgensen
Journal:  Mol Autism       Date:  2019-01-09       Impact factor: 7.509

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.